CIO
APRIL 17, 2024
The victors may not be the greatest innovators, but they’ll be the best at protecting their innovations. A lot of this was incremental innovation around the user interface of coding assistants that developers have been using for 25 years,” says Sonnenblick.
Netbasequid
FEBRUARY 22, 2021
In their paper on Deep Tech: The Great Wave of Innovation , BCG and Hello Tomorrow explain “what deep tech is, how it works, how different stakeholders can contribute to it, and how it can be harnessed for competitive advantage.” How patent intel can reveal emerging innovations. From here, the biotech world is your oyster.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Evalueserve
DECEMBER 6, 2021
Global Healthcare Market – 2021. However, the emergence of a Delta variant of COVID-19 in Europe, the US, and China is fueling the need for ‘booster shots’ to sustain global recovery. According to the IMF, the global economy is likely to grow by 5.9% Global Healthcare M&A: Unprecedented Fightback 2.0.
Alpha Sense BI
FEBRUARY 8, 2023
Specifically, within the pharma and biotech sectors, there have been 22 deals announced so far in 2023 — again, a low number compared to the 70 made over the same period last year. Additionally, unprofitable biopharma, aka most biotech companies, is expected to invest $1.1 In 2021, Spinraza sales reached $1.9
Sedulo
MARCH 15, 2023
Our analysis of global data gathered from multiple trial registries provided a compelling snapshot of the recent IO clinical landscape and prompted several unanswered questions regarding future evolution and the impact on manufacturers competing in the space.
BIS Research
MARCH 19, 2019
Precision medicine is an innovative approach to prevent and treat diseases by taking into account the individual distinction between genetic make-up, lifestyle, and environment of an individual. The global precision market by region is segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.
Alpha Sense BI
MAY 5, 2023
After three volatile years, rife with challenging macroeconomic conditions — from a global pandemic and wars to far-reaching supply chain issues — the M&A space has its fair share of ups and downs. Many pharma companies with expiring patents are on the hunt to acquire biotech companies to address gaps in drug pipelines.
Expert insights. Personalized for you.
812 
Let's personalize your content